These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1954687)

  • 21. Frequency and efficacy of glycoprotein IIb/IIIa therapy for treatment of threatened or acute vessel closure in 1332 patients undergoing percutaneous transluminal coronary angioplasty.
    Haase KK; Mahrholdt H; Schröder S; Baumbach A; Oberhoff M; Herdeg C; Karsch KR
    Am Heart J; 1999 Feb; 137(2):234-40. PubMed ID: 9924156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of antiplatelet drug use in preventing restenosis following percutaneous transluminal coronary angioplasty.
    Cox JL; Gotlieb AI
    Can J Cardiol; 1988 May; 4(4):201-10. PubMed ID: 2456140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The trapidil restenosis trial (STARC study): background, methods and clinical characteristics of the patient population.
    Maresta A; Balducelli M; Cantini L; Casari A; Chioin R; Fontanelli A; Monici Preti PA; Repetto S; Raffaghello S
    Clin Trials Metaanal; 1994 Apr; 29(1):31-40. PubMed ID: 10150183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel approaches for the prevention of restenosis.
    Gruberg L; Waksman R; Satler LF; Pichard AD; Kent KM
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2555-78. PubMed ID: 11060820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Restenosis after percutaneous transluminal coronary angioplasty].
    Aschermann M
    Cas Lek Cesk; 1990 Apr; 129(17):513-5. PubMed ID: 2350767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current status of intravascular stents as delivery devices to prevent restenosis.
    Pearce BJ; McKinsey JF
    Vasc Endovascular Surg; 2003; 37(4):231-7; discussion 237. PubMed ID: 12894364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjunctive intracoronary dipyridamole in the interventional treatment of small coronary arteries: a prospectively randomized trial.
    Heidland UE; Heintzen MP; Michel CJ; Strauer BE
    Am Heart J; 2000 Jun; 139(6):1039-45. PubMed ID: 10827385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical promise of calcium antagonists in the angioplasty patient.
    Thaulow E; Jörgensen B
    Eur Heart J; 1997 May; 18 Suppl B():B21-6. PubMed ID: 9152666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of smooth muscle cell proliferation after balloon angioplasty].
    Hanke H; Karsch KR
    Herz; 1992 Oct; 17(5):300-8. PubMed ID: 1473814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New strategies in the treatment of restenosis].
    von Hodenberg E; Tost B; Scheffold T
    Z Kardiol; 2000; 89 Suppl 7():19-22. PubMed ID: 11098555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies.
    Forrester JS; Fishbein M; Helfant R; Fagin J
    J Am Coll Cardiol; 1991 Mar; 17(3):758-69. PubMed ID: 1993798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic approaches to restenosis prevention.
    Douglas JS
    Am J Cardiol; 2007 Sep; 100(5A):10K-6K. PubMed ID: 17719348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelets and restenosis.
    Chandrasekar B; Tanguay JF
    J Am Coll Cardiol; 2000 Mar; 35(3):555-62. PubMed ID: 10716455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of restenosis after coronary angioplasty: towards a molecular approach?
    Feldman LJ; Riessen R; Steg PG
    Fundam Clin Pharmacol; 1995; 9(1):8-16. PubMed ID: 7768490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing restenosis after coronary angioplasty.
    Popma JJ; Topol EJ
    Am J Med; 1990 Jan; 88(1N):16N-24N. PubMed ID: 2195881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathophysiology of restenosis following percutaneous transluminal coronary angioplasty].
    Holm AM; Haunsø S; Hansen PR
    Ugeskr Laeger; 1998 Feb; 160(9):1302-6. PubMed ID: 9495077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Single-center experience with the Palmaz-Schatz intracoronary stent: the immediate results and medium- and long-term follow-up].
    Galassi AR; Tamburino C; Grassi R; Monaco A; Russo G; Ierna SM; Calvi V; Giuffrida G
    Cardiologia; 1996 Nov; 41(11):1097-105. PubMed ID: 9064207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients.
    Nobuyoshi M; Kimura T; Ohishi H; Horiuchi H; Nosaka H; Hamasaki N; Yokoi H; Kim K
    J Am Coll Cardiol; 1991 Feb; 17(2):433-9. PubMed ID: 1991900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Restenosis after percutaneous transluminal coronary angioplasty and its prevention].
    Przewłocka-Kosmala M; Kosmala W
    Przegl Lek; 1999; 56(10):671-5. PubMed ID: 10695384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized comparison of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, versus aspirin in prevention of angiographic restenosis after coronary artery Palmaz-Schatz stent implantation.
    Galassi AR; Tamburino C; Nicosia A; Russo G; Grassi R; Monaco A; Giuffrida G
    Catheter Cardiovasc Interv; 1999 Feb; 46(2):162-8. PubMed ID: 10348536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.